Andere Sprachen Zai Lab Limited

Aktien

A2DX1V

US98887Q1040

ZLAB

Pharmazeutika

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 04.12.2024			% 5 Tage	% 1. Jan.
28.31 ^USD	-6.13%		+0.64%	+3.59%

04.12.	Asiatische Aktien in den USA als American Depositary Receipts im Mittwochshandel niedriger gehandelt	MT
04.12.	Zai Lab Limited Presents at Citi's 2024 Global Healthcare Conference, Dec-04-2024 09:30 AM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading	04.12.
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	03.12.
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields Therapy for Pancreatic Cancer	03.12.
NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint	02.12.
Sector Update: Health Care Stocks Mixed Pre-Bell Monday	02.12.
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Monday Ahead of Week Promising Crucial Economic Data	02.12.
Zai Lab, NovoCure Say Pancreatic Cancer Trial Meets Primary Endpoint	02.12.
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer	02.12.
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields Therapy for Pancreatic Cancer	02.12.
Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List	29.11.
Zai Lab Announces the Inclusion of AUGTYRO for ROS1+ NSCLC and Other Updates in China's National Reimbursement Drug List	28.11.
Zai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List	28.11.
Zai Lab Limited Announces the Inclusion of Augtyro (Repotrectinib) for Ros1+ Nsclc and Other Updates in China?S National Reimbursement Drug List	28.11.
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading	25.11.
Zai Lab Raises $216 Million Through ADS Offering	25.11.
Sector Update: Health Care Stocks Rise Pre-Bell Thursday	21.11.
Zai Lab, Pfizer Collaborate for Marketing Antibacterial Drug in China	21.11.
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)	21.11.
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug Xacduro® (Sulbactam-Durlobactam)	21.11.
Zai Lab Grants Share Units to Employees	20.11.
Asian Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading	19.11.
Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	18.11.
Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares	18.11.
Zai Lab : Announces Pricing of Public Offering of American Depositary Shares Form 8 K	15.11.
Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down Over 3% for Week	15.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Zai Lab Limited

Aktien

A2DX1V

US98887Q1040

ZLAB

Pharmazeutika

Andere Sprachen

Filter